Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer
Tian Tian, Yangzhi Zhao, Jingying Zheng, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 63-80
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 87
RNA therapeutics: updates and future potential
Caroline Zhang, Biliang Zhang
Science China Life Sciences (2022) Vol. 66, Iss. 1, pp. 12-30
Open Access | Times Cited: 75
Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging miR-1205
Yan Zeng, Wei Du, Zhongying Huang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 42
Circular RNAs as Potential Biomarkers in Breast Cancer
Fatima Domenica Elisa De Palma, Francesco Salvatore, Jonathan Pol, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 725-725
Open Access | Times Cited: 33
CircHGF suppressed cell proliferation and osteogenic differentiation of BMSCs in ONFH via inhibiting miR-25-3p binding to SMAD7
Xiaobo Feng, Qian Xiang, Jie Jia, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 99-113
Open Access | Times Cited: 32
Inhibition of breast cancer cell growth and migration through siRNA-mediated modulation of circ_0009910/miR-145-5p/MUC1 axis
Maryam Abtin, Nahid Nafisi, Asghar Hosseinzadeh, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 367-375
Open Access | Times Cited: 5
Target-Initiated Cascade Signal Amplification Lights up a G-Quadruplex for a Label-Free Detection of Circular Ribonucleic Acids
Shu-hua Wei, Meng Liu, Juan Hu, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 25, pp. 9193-9200
Closed Access | Times Cited: 24
CircNCOR1 regulates breast cancer radiotherapy efficacy by regulating CDK2 via hsa-miR-638 binding
Zhen-Yu He, Rengong Zhuo, Shi‐Ping Yang, et al.
Cellular Signalling (2023) Vol. 109, pp. 110787-110787
Closed Access | Times Cited: 12
CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis
Jiulong Ma, Chen Chen, Zhimin Fan, et al.
International Journal of Biological Macromolecules (2023) Vol. 244, pp. 125295-125295
Closed Access | Times Cited: 10
Circular RNAs modulate Hippo-YAP signaling: functional mechanisms in cancer
Javeria Qadir, Feiya Li, Burton B. Yang
Theranostics (2022) Vol. 12, Iss. 9, pp. 4269-4287
Open Access | Times Cited: 16
CircSEPT9 promotes breast cancer progression by regulating PTBP3 expression via sponging miR‐625‐5p
Guangtao Shi, Hongbo Li, Ying Chen, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 10, pp. 808-819
Open Access | Times Cited: 2
Human disease biomarker panels through systems biology
Bradley J. Smith, Lícia C. Silva-Costa, Daniel Martins‐de‐Souza
Biophysical Reviews (2021) Vol. 13, Iss. 6, pp. 1179-1190
Open Access | Times Cited: 20
New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
Yeqin Fu, Qiuhui Yang, Hongjian Yang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 7
Exosomes in triple negative breast cancer: From bench to bedside
Weiqiang Tang, Min Xia, Yajie Liao, et al.
Cancer Letters (2021) Vol. 527, pp. 1-9
Closed Access | Times Cited: 19
Research Progress of circRNAs in Glioblastoma
Xu Guo, Haozhe Piao
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 17
circGFRA1: A circular RNA with important roles in human carcinogenesis
Sheyda Khalilian, Zahra Mohajer, Mohammad Amin Khazeei Tabari, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154588-154588
Closed Access | Times Cited: 6
The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects
Xingjia Lu, Jian Zhong, Linlin Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms
Fei Liu, Shenglong Li
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Circ_0081723 enhances cervical cancer progression and modulates CREBRF via sponging miR-545-3p
Qiongyan Ma, Weiwei Yu, Zhaobin Li, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8839-8852
Closed Access | Times Cited: 1
CRISPR/Cas genome editing in triple negative breast cancer: Current situation and future directions
Leilei Fu, Zixiang Li, Yueting Ren, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115449-115449
Closed Access | Times Cited: 4
Transforming Growth Factor-β1-mediated Regulation of circ_DISP3 and ATF3 in Human Triple-negative Breast Cancer Cells
S. Mohan, Ashok Bharathy, Magesh Induja, et al.
Gene Expression (2023) Vol. 22, Iss. 4, pp. 297-305
Open Access | Times Cited: 4
WASF3 overexpression affects the expression of circular RNA hsa-circ-0100153, which promotes breast cancer progression by sponging hsa-miR-31, hsa-miR-767-3p, and hsa-miR-935
Majid Mokhtari, Samane Khoshbakht, Mohammad Esmaeil Akbari, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22874-e22874
Open Access | Times Cited: 4
Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC)
Abhishek Kanugo, Rupesh K. Gautam, Mohammad Amjad Kamal
Current Pharmaceutical Biotechnology (2021) Vol. 23, Iss. 13, pp. 1581-1595
Closed Access | Times Cited: 9
Circular RNAs in the chemoresistance of triple‐negative breast cancer: A systematic review
Hongmei Wang, Xuefeng Shan, Yang Peng, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 805-814
Closed Access | Times Cited: 3
circ_0058063 promotes breast cancer progression by upregulating DLGAP5 via sponging miR-557
Kongjun Zhu, Cen Yi, Chuanming Tong
Cancer Biomarkers (2023) Vol. 39, Iss. 1, pp. 1-13
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top